Buscar
Mostrando ítems 71-80 de 1337
Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection
(2017)
Human Respiratory syncytial virus (hRSV) and human metapneumovirus (hMPV) are the two major etiological viral agents of lower respiratory tract diseases, affecting mainly infants, young children and the elderly. Although ...
Respiratory Syncytial Virus: Pathology, therapeutic drugs and prophylaxis
(2014)
Human Respiratory Syncytial Virus (hRSV) is the leading cause of lower respiratory tract diseases, affecting particularly newborns and young children. This virus is able to modulate the immune response, generating a ...
Surface expression of human Respiratory Syncytial Virus (hRSV) Nucleoprotein inhibits immunological synapse assembly by T cells
(2015)
The human Respiratory Syncytial Virus (hRSV) is the major cause of children severe respiratory tract infections worldwide. Both, the
poor activation of T cells and the limited generation of memory T cells following disease ...
Characterization of the expression of T cell receptor Vβ chains in response to infection by the respiratory syncytial virus
(2011)
The respiratory Syncytial Virus (RSV) is the leading cause of childhood hospitalizations for acute respiratory illnesses. In Chile, annual new RSV outbreaks cause the collapse of the public health system in public hospitals. ...
Characterization of T cell receptor Vβ usage in response to the Respiratory Syncytial Virus
(2012)
Introduction: Respiratory Syncytial Virus (RSV) is the major cause of bronchiolitis in infants worldwide. The pathology caused by this virus has been associated with exacerbated host immune response in a T cell-dependent ...
A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus
(2017)
The human Respiratory Syncytial Virus (hRSV) causes lower respiratory tract infections including pneumonia and bronchiolitis. Such infections also cause a large number of hospitalizations and affects mainly newborns, young ...
Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia-Implications for Vaccine Design
(2017)
The human respiratory syncytial virus (hRSV) is the causative agent for high rates of hospitalizations due to viral bronchiolitis and pneumonia worldwide. Such a disease is characterized by an infection of epithelial cells ...
Contribution of Fc gamma receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells
(2016)
Human respiratory syncytial virus (hRSV) is the leading cause of infant hospitalization related to respiratory disease. Infection with hRSV produces abundant infiltration of immune cells into the airways, which combined ...
A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus
(2017)
The human Respiratory Syncytial Virus (hRSV) causes lower respiratory tract infections including pneumonia and bronchiolitis. Such infections also cause a large number of hospitalizations and affects mainly newborns, young ...
Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia-Implications for Vaccine Design
(2017)
The human respiratory syncytial virus (hRSV) is the causative agent for high rates of hospitalizations due to viral bronchiolitis and pneumonia worldwide. Such a disease is characterized by an infection of epithelial cells ...